The following recommendations were updated by NTAG at their meeting on the 23rd February 2021 and are now available on the website:
- Flash Glucose Monitoring – updated to include Learning Disability on insulin, and use in pregnancy on insulin with Type 2 diabetes as additional criteria. Plus information on switch to Freestyle Libre 2 and extra guidance on use in Type 1 diabetes patient with high HbA1c.
- Teriparatide for atypical bisphosphonate induced fractures – reviewed and no changes made.
- Doxylamine/Pyridoxine (Xonvea®) for nausea & vomiting in pregnancy – reviewed and no changes made.
The recommendations were archived by NTAG at their meeting on the 23rd February 2021 as now superseded by NICE TA or NHSE guidance:
- Erenumab and galcanezumab for prophylaxis of migraine
- Brolucizumab for wAMD